Lisa Delfini
Chief Financial Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Trevi Therapeutics, Inc. (TRVI) | Chief Financial Officer | $412,169 | $1,187,403 |
| 2023 | Trevi Therapeutics, Inc. (TRVI) | Chief Financial Officer | — | — |
Executive changes
Earnings-call appearances
-
Trevi Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-07
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q1 FY2025 Earnings Call2025-06-02
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q4 FY2024 Earnings Call2025-03-18
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-06
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-08
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-07
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-20
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-09
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-10
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-11
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q4 FY2022 Earnings Call2023-03-16
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-10
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-11
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-12
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-17
Trevi Therapeutics, Inc. (TRVI)
-
Trevi Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-10
Trevi Therapeutics, Inc. (TRVI)